Sandoz TV Episode 18: Trailer
Find out what to expect from the newest episode of Sandoz TV.
|Global News||Sandoz Around the World||Sandoz in the Media|
Sandoz receives approvals in Ireland and Sandoz launches innovative respiratory inhaler AirFluSal® Forspiro® in Portugal and Ireland
Holzkirchen, March 11, 2015
Sandoz today announces the launch of AirFluSal® Forspiro®, an innovative inhaler for patients with asthma and/or chronic obstructive pulmonary disease (COPD), in Portugal and Ireland.
FDA approves first biosimilar Zarxio™ (filgrastim-sndz) from Sandoz
Holzkirchen, March 06, 2015
Sandoz, a Novartis company, announced today that the US Food and Drug Administration (FDA) approved Zarxio™ (filgrastim-sndz) for all indications included in the reference product’s label.
Sandoz announces training program for midwives in Ethiopia, to reduce maternal and newborn mortality
Holzkirchen, Germany, March 02, 2015
Sandoz today announced the launch of a new program, New Life & New Hope, to improve maternal and child health and reduce mortality associated with childbirth.
Novartis announces completion of transactions with GSK
Basel, March 02, 2015
Novartis announced today that it has completed a series of transactions with GlaxoSmithKline plc (GSK).
On World Cancer Day, Sandoz highlights global problem of child cancer
February 04, 2015
Today is World Cancer Day and this year, under the theme ‘Not beyond us,’ Sandoz highlights the global burden of child cancer and the solutions that do exist.